Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury

Part of paid clinical trials in Clearwater, Florida.

Sponsor
BayCare Health System
Study ID
NCT07197957
Status
Recruiting
Apply to this trial

Conditions

  • Acute Kidney Injury

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).

Key Dates

Start date
Mar 11, 2025
Status verified
Sep 2025
Primary completion
Feb 28, 2026
Completion
Feb 28, 2027

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Incidence of AKI when sCr is used compared to when sCyC is used 24-48 hours after contract media and at 7-10 days follow-up [ Time Frame: 10 days ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Morton Plant HospitalClearwaterFlorida33756
Andrea Daigneault, RN
[email protected]
727-754-9028
Morton Plant North Bay HospitalNew Port RicheyFlorida34652
Enrique Rincon, MD
[email protected]
727-375-7929
Mease Countryside HospitalSafety HarborFlorida34695
Jonathan Frunzi, MD
[email protected]
(727) 725-6111
St. Anthony's HospitalSt. PetersburgFlorida33705
Sarah Al-Obaydi, MD
[email protected]
727-825-1236

Find similar trials in Clearwater, FL

By research site
Morton Plant Hospital· Clearwater, FLMorton Plant North Bay Hospital· New Port Richey, FLMease Countryside Hospital· Safety Harbor, FLSt. Anthony's Hospital· St. Petersburg, FL

Related Studies